Status

This opportunity is still open. If interested in submitting, please contact Logan Schmidt (-6287) as soon as possible.

Deadlines
  • Internal: 03/24/2018
  • Proposal: 05/25/2018

Funding

  • Amount: Up to $1.5M per year
  • Duration: Up to 5 years

Scope

This funding opportunity announcement (FOA) for the RM1 grant mechanism replaces the NIGMS P01 program. It encourages Collaborative Program Grant applications from institutions/organizations that propose to conduct research to address complex and challenging biomedical problems, important for the mission of NIGMS, through deeply integrated, multidisciplinary research teams. The Collaborative Program Grant is designed to support research in which funding a team of interdependent investigators offers significant advantages over support of individual research project grants. Applications should address critical issues and be sufficiently challenging, ambitious, and innovative that objectives could not be achieved by individual investigators.

Successful Collaborative Program Grant applications will bring together scientists to apply complementary approaches to work on an important and well-defined problem. Applications may address any area of science within the NIGMS mission, which is to support basic research that increases understanding of biological processes at a range of levels, from molecules and cells to tissues, whole organisms and populations. NIGMS also supports research in a limited number of clinical areas that affect multiple organ systems (see here for scientific areas supported by NIGMS). Truly new interdisciplinary ideas for approaching significant biological problems are encouraged. Applications that bridge the research interests of more than one NIGMS division are also encouraged, but must remain within the scope of the NIGMS mission. Consultation with NIGMS staff (see below) prior to preparing an application is strongly encouraged.

Applications for smaller projects with one or two PD/PIs should consider submitting a multi-PD/PI application to the “NIH Research Project Grant (Parent R01)” FOA (see the Parent Announcement website for the current issuance of this FOA). Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, or on infrastructure development are not appropriate for this FOA. Although Collaborative Program Grants may include some technology development, applications with a central focus on the creation of new technologies would not be considered for funding as a Collaborative Program Grant and are more appropriate for other NIGMS mechanisms for funding technology research and resources.

Applications that employ specific cells or tissues to address a fundamental biomedical question are appropriate. However, applications that focus solely on a specific organ or disease state and that are within the mission areas of other NIH Institutes and Centers would not be appropriate for this FOA. All clinical research must be completely within the context of NIGMS clinical areas (anesthesiology and peri-operative pain; clinical pharmacology; sepsis; trauma, burn injury and wound healing). Finally, NIH-defined clinical trials are not allowed.

Eligibility & Submission Requirements

Only one application per institution is allowed for the Collaborative Research Program Grant (RM1) per review cycle.

If you are interested submitting, please contact Logan Schmidt (-6287) as soon as possible and submit a 2-page pre-proposal following the NU Procedure for Programs with Limited Submissions.

Contact Information

Scientific/Research Contact(s)

Paul Sammak, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Telephone: 301-594-8494
Email: paul.sammak@nih.gov